Heron Therapeutics, Inc. (HRTX): Free Cash Flow
-$27.91M
Year ended 2025-12-31
-$12.13M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$27.91M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$24.23M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$60.33M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$148.74M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$206.38M | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$191.63M | n/m | 2022-02-28, From 2020-01-01 |
| 2019-12-31 | -$131.73M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$200.98M | n/m | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | -$172.85M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$137.23M | n/m | 2019-02-22, From 2016-01-01 |
| 2015-12-31 | -$79.61M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | -$61.72M | n/m | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | -$42.45M | n/m | 2016-02-19, From 2013-01-01 |
| 2012-12-31 | -$17.98M | n/m | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | -$8.23M | n/m | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | -$5.56M | n/m | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | -$11.00M | n/a | 2012-03-26, From 2009-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$27.91M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$40.02M | n/m |
| Macrogenics Inc (MGNX) | 2025-12-31 | -$82.95M | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $22.82M | +291.4% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$75.37M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$323.17M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$167.00M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | -$25.02M | n/m |
| Lifevantage Corp (LFVN) | 2026-06-30 | $6.67M | -36.5% |
Compare HRTX, LQDA, MGNX, ELTP side by side · Screen every company in Pharmaceutical Preparations ↗